Product Description
Overall, the U.S. pain management device market was valued at $6.2 billion in 2025. This is expected to increase over the forecast period at a CAGR of 3.4% to reach $7.8 billion.
The full report suite on the U.S. market for pain management devices includes spinal cord stimulator, deep brain stimulator, responsive neurostimulation device, peripheral nerve stimulation (PNS), intrathecal pump, syringe pump, patient-controlled analgesia (PCA) pump, electronic ambulatory pump, surgical post-operative disposable ambulatory pain pump, peripheral nerve block (PNB), regional anesthesia, radiofrequency ablation and anesthesia point-of-care ultrasound (POCUS).
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Pain Management Device Market Trends
As the demand for non-opioid or pharmaceutical pain relief rises, more companies are investing in the variety of markets that support that demand. Of the 13 markets included in this report, many have seen multiple launches of new models within existing product lines that feature new tools for doctors, including multiple configurations, artificial intelligence (AI) capabilities and more compact designs. Over the reporting period, this trend is expected to continue.
Pain Management Device Market Share Insights

- Medtronic was the leading company in the U.S. pain management device market in 2025. The company held significant shares in spinal stimulation, deep brain stimulation, intrathecal pumps and radiofrequency ablation. As Medtronic was the first company to release a spinal cord stimulation (SCS) product, it has brand recognition, a strong reputation and established relationships with physicians.
- Abbott was the second-leading company in the total pain management device market. The company is active in most of the radiofrequency ablation market. The company has two lines of needles: the classic and SL premium
- Boston Scientific was the third-leading company in the pain management device market in 2025. The company held significant shares in spinal stimulation, deep brain stimulation and radiofrequency ablation. The company has the Vercise Genus™, a fourth-generation deep brain stimulation (DBS) device.
Pain Management Device Market Segmentation Summary
- Spinal Cord Stimulator Market – Further Segmented Into:
- Device Type: Generators and Leads.
- Deep Brain Stimulation Market
- Responsive Neurostimulation Market
- Peripheral Nerve Stimulation Market – Further Segmented Into:
- Device Type: Pain Treatment PNS, and Pain Medication Placement PNS.
- Intrathecal Pump Market
- Syringe Pump Market – Further Segmented Into:
- Care setting: Hospitals, Ambulatory Surgical Centers, and Home Care Settings.
- Modularity: Modular, and Non-Modular.
- Patient-Controlled Analgesia Pump Market – Further Segmented Into:
- Care setting: Hospitals, Ambulatory Surgical Centers, and Home Care Settings.
- Electronic Ambulatory Pump Market – Further Segmented Into:
- Care setting: Hospitals, Ambulatory Surgical Centers, and Home Care Settings.
- Surgical Post-Operative Disposable Ambulatory Pain Pump Market – Further Segmented Into:
- Care setting: Hospitals, Ambulatory Surgical Centers, and Home Care Settings.
- Peripheral Nerve Block Market – Further Segmented Into:
- Device Type: Peripheral Nerve Block Disposable Ambulatory Disposable Pump, Continuous, and Single-Shot.
- Regional Anesthesia Market – Further Segmented Into:
- Device Type: CSE, Epidural, and Spinal.
- Accessory: Needle Set and Tray.
- Approach: Direct and Indirect.
- Radiofrequency Ablation Market – Further Segmented Into:
- Device Type: Generator, Needle, and Cannula.
- Anesthesia Point-of-Care Ultrasound Market – Further Segmented Into:
- Device Type: Cart-Based and Hand Carry.
- Function: Regional and General.
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | United States |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.